Adaptimmune Therapeutics | ARS: Annual Report to Security Holders
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | DEF 14A: Definitive information statements
Adaptimmune Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%), etc.
Adaptimmune Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Adaptimmune Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner EcoR1 Capital, LLC
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%), etc.
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Piccina Cintia
Adaptimmune Therapeutics | 10-K: Annual report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%), etc.
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%), etc.
Adaptimmune Therapeutics | 8-K: Current report
Adaptimmune Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%), etc.
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(7.01%)
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rawcliffe Adrian
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bertrand William C JR
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lunger John
No Data